These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2388887)

  • 21. [Secondary immunodeficiency and its correction with thymus preparations in patients with postabortion endometritis].
    Franchuk AE; Benzar ZT
    Akush Ginekol (Mosk); 1990 Sep; (9):40-3. PubMed ID: 2278306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chronic liver diseases: secondary thymic insufficiency and immunocorrection with T-activin].
    Sarkisian SV
    Klin Med (Mosk); 1994; 72(6):45-8. PubMed ID: 7898010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The immunological criteria in the expediency of prescribing T-activin to patients with primary pulmonary tuberculosis].
    Sakhelashvili-Haladzhun MI
    Lik Sprava; 1994; (9-12):103-5. PubMed ID: 7604543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevention of side effects of specific chemotherapy in patients with pulmonary tuberculosis].
    Batian AN; Abramovskaia AK; Batian ON
    Probl Tuberk; 1991; (7):60-2. PubMed ID: 1754594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tactivin in combined treatment of patients with pulmonary tuberculosis associated with gastrointestinal diseases].
    Zhukova EM
    Probl Tuberk; 1995; (3):25-7. PubMed ID: 7617628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The use of T-activin in the intensive therapy of the postoperative period in gestosis patients].
    Ianiushina VV
    Anesteziol Reanimatol; 1992; (4):42-5. PubMed ID: 1485674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effectiveness of antitubercular chemotherapy combined with corticosteroids and immunomodulators].
    Khomenko IS; Chukanov VI; Gergert VIa; Utkin VV
    Probl Tuberk; 1990; (1):24-8. PubMed ID: 2336431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prospects of using immunocorrective treatment with an active thymus factor (taktivin) in dermatology].
    Skripkin IuK; Korotkiĭ NG; Udzhukhu VIu; Arion VIa; Eletskiĭ AIu
    Vestn Dermatol Venerol; 1986; (4):4-7. PubMed ID: 3487189
    [No Abstract]   [Full Text] [Related]  

  • 29. [The efficacy of immunomodulating preparations in treating patients with chronic cholestatic liver diseases].
    Radchenko VG; Mitrofanova TI; Serebriakova VI; Vinogradova GL
    Lik Sprava; 1992; (11-12):38-41. PubMed ID: 1292217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The correction of disorders in the cytoenzymatic status of the immunocytes in Shigella infection by using taktivin].
    Guliamov N; Kriuchkov MI
    Ter Arkh; 1991; 63(11):27-30. PubMed ID: 1810056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [T-activin in the complex treatment of patients with pulmonary tuberculosis].
    Ivanova LA; Pavlova MV
    Probl Tuberk; 1986; (5):37-40. PubMed ID: 3488548
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of thymalin on the nonspecific resistance of pulmonary tuberculosis patients].
    Rybalko VV; Brazhenko NA; Khavinson VKh
    Voen Med Zh; 1986 May; (5):34-6. PubMed ID: 3755557
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunological indicators in children with laryngeal papillomatosis and possible ways of immunocorrection].
    Garashchenko TI; Markova TP; Chuvirov DG
    Vestn Otorinolaringol; 1996; (4):15-8. PubMed ID: 8966870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Principles of immunocorrective therapy using the thymus preparation T-activin].
    Arion VIa; Ivanushkin EF
    Khirurgiia (Mosk); 1984 Nov; (11):44-8. PubMed ID: 6335205
    [No Abstract]   [Full Text] [Related]  

  • 35. Influence of thymic preparations on the result of experimental infection with Taenia crassiceps (Zeder, 1800) in ICR mice.
    Hermánek J; Prokopic J
    Folia Parasitol (Praha); 1989; 36(4):331-40. PubMed ID: 2488049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [T-lymphocyte subpopulations in autoimmune and subacute thyroiditis treated with T-activin].
    Sakaeva NA; Balabolkin MI; Tabagari DZ
    Sov Med; 1989; (10):39-41. PubMed ID: 2617340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of thymalin in trauma patients].
    Gurevich KIa; Khavinson VKh; Morozov VG
    Vestn Khir Im I I Grek; 1984 Feb; 132(2):52-4. PubMed ID: 6547012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Indices of cellular and humoral immunity in patients with disseminated sclerosis being treated with immunomodulators].
    Zapadniuk BV; Kravets AS; Iarosh AA; Shurinok LA
    Vrach Delo; 1988 Aug; (8):84-6. PubMed ID: 3206892
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effectiveness of administration of thymalin in the complex treatment of pulmonary tuberculosis].
    Kogosova LS; Chernushenko EF; Il'nitskiĭ IG; Goncharova SI; Markov AE; Kuchugura-Kucherenko LV
    Probl Tuberk; 1990; (10):29-32. PubMed ID: 2080155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The use of thymus preparations in treating patients with rheumatic diseases].
    Svintsitskiĭ AS
    Ter Arkh; 1991; 63(5):137-40. PubMed ID: 1887397
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.